Top News

New Delhi: The upcoming board meeting of Sudarshan Pharma Industries on June 19 2025 holds significant importance as it will consider and approve the proposal of raising funds. The company may opt for the issuance of equity shares or warrants to raise these funds as per an exchange filing. The companys statement to the exchanges reads The board of directors of the company will meet on Thursday 19th April 2025 inter alia to consider evaluate and approve the proposal of raising funds by way of issuance of equity shares or any other equity-linked instruments or securities including convertible instruments warrants etc. subject to applicable approvals. The shares of Sudarshan Pharma Industries opened with a notable loss of nearly two per cent at Rs 28.82 compared to the previous close of Rs 29.40 on the BSE underscoring the companys current stock performance. The 52-week high of the stock is Rs 53.50 and the 52-week low is Rs 7.35. The market cap of the company is Rs 693.58. The stock has been falling for the last six days and has fallen 11.3 per cent in the period. This detailed information about the stocks performance provides investors with a comprehensive understanding of the companys current standing. Its worth noting that Sudarshan Pharma Industries stock is currently trading below the 5-day 20-day 50-day 100-day and 200-day moving averages indicating a downward market trend. Share Price History The stock has given a multibagger return of 295 per cent in one year and 326 per cent in two years. However it has corrected over 35 per cent so far this year. Meanwhile homegrown pharma company Sudarshan Pharma Industries which manufactures sources and distributes chemicals and pharmaceutical products has informed exchanges that the Government of India has granted it a certificate of recognition - One Star Export House. This prestigious recognition is a testament to the companys commitment to excellence and its contribution to the pharmaceutical industry making stakeholders feel proud to be associated with Sudarshan Pharma Industries. The company has received certificate of recognition - One Star Export House by the Directorate General of Foreign Trade of the Department of Commerce Ministry of Commerce and Industry Government of India and the same shall be valid for a period of 5 years effective from 8th May 2024 up to 31st March 2028 the company said in an exchange filing. This government certification signifies that the company has demonstrated excellent performance in international trade and achieved a certain level of export performance. It is categorised in five levels from One Star to Five Star.